PFE Pfizer Inc.
Exchange
NYSESector
Consumer DurablesIndustry
Major PharmaceuticalsMarket Cap.
204.1BShare your thoughts about PFE
Sign Up or Log In to start contributing!
Posted by Robert.T (on March 21, 2012)
Yeah, there are definitely going to be some carcasses once this melee around patent expiration finishes.
Pfizer is an interesting case. They've been around forever and it's hard to imagine that they'll just disappear. At the same time, the facts don't look promising. For example, they recently put out a (much hyped) rheumatoid arthritis treatment and it's not so hot. 55% of doctors said it wouldn't replace drugs they currently prescribe patients. Here's the link to the full article: http://www.pharmalot.com/2012/03/pfizers-rheumatoid-arthritis-pill-not-a-slam-dunk/
Pfizer is an interesting case. They've been around forever and it's hard to imagine that they'll just disappear. At the same time, the facts don't look promising. For example, they recently put out a (much hyped) rheumatoid arthritis treatment and it's not so hot. 55% of doctors said it wouldn't replace drugs they currently prescribe patients. Here's the link to the full article: http://www.pharmalot.com/2012/03/pfizers-rheumatoid-arthritis-pill-not-a-slam-dunk/
Furthermore, its a large cap stock so there's probably a lot of investor speculation, herding and rebalancing of portfolios that is going to affect the value.
Plus the pharma market is starting to lose all their patents without putting any new drugs out ...
I wouldn't invest ...